Latest Breaking News On - Henriette wennicke - Page 4 : comparemela.com

Zealand Pharma (ZEAL) Enters EUR 90M Finance Agreement with the European Investment Bank

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 42 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons .

Zealand Pharma Announces Financial Results for the First Nine Months of 2023

Company announcement - No. 38 / 2023 Zealand Pharma Announces Financial Results for the First Nine Months of 2023 Strong progress across obesity pipeline, first PDUFA date for dasiglucagon in CHI in 2023 and solid financial position Boehringer Ingelheim advances GCGR/GLP-1R dual agonist survodutide (BI456906) into Phase 3 trials in obesityZealand presents amylin analog ZP8396 6-week trial results at ObesityWeek and initiates GLP-1R/GLP-2R dual agonist dapiglutide 13-week dose titration trialZeal

Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results

Press Release – No. 14 / 2023 Zealand Pharma conference call on November 9 at 2pm CET to present third quarter 2023 results Copenhagen, Denmark, November 3, 2023 – a Zealand.

Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results